Clinical trial
Hypofractionated Radiotherapy for Small Cell Lung Cancer
NCT00469222 · AHS Cancer Control Alberta, Other · Completed
Key facts
| NCT number | NCT00469222 |
|---|---|
| Title | Hypofractionated Radiotherapy for Small Cell Lung Cancer |
| Official title | Phase I Dose Escalation Trial of Hypofractionated Limited-field External Beam Thoracic Radiotherapy for Limited Stage Small Cell Carcinoma of the Lung |
| Lead sponsor | AHS Cancer Control Alberta, Other |
| Collaborators | Cross Cancer Institute |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Neoplasm, Small Cell Carcinoma |
| Intervention type | Procedure |
| Interventions | hypofractionated external beam |
| Enrollment | 24 |
| Start date | Mar 1, 2007 |
| Primary completion | Apr 1, 2011 |
| Completion | Apr 1, 2011 |
| First posted | May 4, 2007 |
| Last update posted | Feb 25, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: